Eyenovia to Report Fourth Quarter and Full Year 2020 Results on Thursday, March 25
Company to host an investor conference call and webcast at 4:30pm ET on that dayNEW YORK, March 18, 2021 (GLOBE...
Company to host an investor conference call and webcast at 4:30pm ET on that dayNEW YORK, March 18, 2021 (GLOBE...
FLORHAM PARK, N.J., March 18, 2021 (GLOBE NEWSWIRE) -- Celularity Inc. (“Celularity”), a clinical-stage biotechnology company, leading the next evolution...
BIO-Europe Spring 2021Kempen Life Sciences Conference4th SACHS Annual Neuroscience Innovation Forum 2021 MADRID, Spain and CAMBRIDGE, Mass., March 18, 2021...
Niagara Falls, NY , March 18, 2021 (GLOBE NEWSWIRE) -- Positron Corp (“Positron” or the “Company”) (OTC: POSC) is pleased...
ATLANTA, March 18, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a pharmaceutical company that specializes in the...
- FHD-286 Phase 1 data anticipated as early as year-end 2021 - FHD-609 IND submission on track for the second...
‒ Achieved Primary Endpoint in EB613 Phase 2 Clinical Trial ‒‒ Final Data, Including Bone Mineral Density, Expected in Q2:21...
Conference Call Scheduled for March 25, 2021 at 4:30 p.m. ETRAMSEY, N.J. and BOCA RATON, Fla., March 18, 2021 (GLOBE...
HIGHLANDS RANCH, Colo., March 18, 2021 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company...
MENLO PARK, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative...
SEATTLE, March 18, 2021 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to...
Pyxis expands developmental capabilities with license to two ADC programs and ADC technology platform toolkit developed by PfizerCAMBRIDGE, Mass., March...
SAN FRANCISCO, March 18, 2021 (GLOBE NEWSWIRE) -- Augmedix, Inc. (OTC Pink: AUGX), a leading provider of remote medical documentation...
SAN MATEO, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Acepodia, a biotechnology company developing next generation solid tumor and hematologic...
$262.3 million cash balance at the end of 2020 bolstered by additional net proceeds of $211.3 million from follow-on offering,...
SOUTH SAN FRANCISCO, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that data from a...
DUBLIN, Ireland, March 18, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an...
Conference Call and Webcast Today at 8:30 a.m. ET COVID-19 vaccine candidate, COVAXIN™, demonstrates efficacy of 81% in Phase 3...
Toronto, Ontario--(Newsfile Corp. - March 18, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), a progressive medical...
Skyflow Delivers Data Security, Interoperability, and Compliance with Healthcare Data Privacy Vault PALO ALTO, Calif.--(BUSINESS WIRE)--#API--Skyflow today announced that its...